A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells

Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways

(2014) Fabienne Guillaumond et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Molecular pathology of pancreatic cancer

(2014) Yuriko Saiki et al.   PATHOLOGY INTERNATIONAL

The role of FAK in tumor metabolism and therapy

(2013) Jianliang Zhang et al.   PHARMACOLOGY & THERAPEUTICS

Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase

(2012) Alexander Schultze et al.   Anti-Cancer Agents in Medicinal Chemistry

Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth

(2012) Deniz A. Ucar et al.   CELL CYCLE

Signaling Pathways in Pancreatic Cancer

(2012) Meir Preis et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

387 The Focal Adhesion Kinase Inhibitor GSK2256098: a Potent and Selective Inhibitor for the Treatment of Cancer

(2012) K.R. Auger et al.   EUROPEAN JOURNAL OF CANCER

A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer

(2011) Steven N. Hochwald et al.   CELL CYCLE

Phosphorylation of Focal Adhesion Kinase at Tyr397 in Gastric Carcinomas and its Clinical Significance

(2010) I-Rue Lai et al.   AMERICAN JOURNAL OF PATHOLOGY

An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression

(2009) Jay S Desgrosellier et al.   NATURE MEDICINE

FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells

(2008) Weiguo Liu et al.   CARCINOGENESIS